Restless Legs Syndrome and Perimenopause: A Deep Dive Into Causes and Treatment
Restless legs syndrome worsens significantly during perimenopause. This in-depth guide covers the hormonal connection, triggers, and treatment options.
Understanding Restless Legs Syndrome
Restless legs syndrome (RLS), also called Willis-Ekbom disease, is a neurological condition characterised by an irresistible urge to move the legs, typically accompanied by uncomfortable sensations described as crawling, tingling, aching, itching, or a deep unpleasant pressure beneath the skin. The sensations occur predominantly at rest, particularly when lying down or sitting, and are relieved temporarily by movement. Symptoms follow a circadian pattern, worsening in the evening and nighttime. This timing is clinically important because it means RLS is one of the most common causes of insomnia and sleep maintenance problems in perimenopausal women. The condition is often dismissed by clinicians as anxiety, growing pains, or poor circulation. If you have an irresistible urge to move your legs at night that is relieved by movement and worsened by rest, and the pattern has no other explanation, RLS should be considered.
The Perimenopause and Hormonal Connection
Studies consistently show that RLS prevalence increases in women during perimenopause and postmenopause compared to premenopausal women of the same age. Women are already more prone to RLS than men throughout life, with prevalence roughly twice as high, and this disparity increases further around the menopausal transition. The mechanisms are not fully established, but several pathways are proposed. Estrogen modulates dopamine activity in the central nervous system. Dopamine pathways in the brain are central to the regulation of the motor and sensory abnormalities of RLS. Declining estrogen may reduce dopaminergic tone in the spinal cord and brain regions that suppress the urge to move. Progesterone also has sedating and anticonvulsant properties that help dampen abnormal sensory activity. Its decline may lower the threshold at which these uncomfortable sensations arise. Iron deficiency, which can develop through heavy perimenopause periods, is a direct trigger for RLS as iron is required for dopamine synthesis.
Key Triggers and Aggravating Factors
Identifying and removing triggers often significantly reduces RLS severity without medication. Iron deficiency is the most important reversible cause of secondary RLS. Serum ferritin is the best measure of iron stores, and values below 75 micrograms per litre are associated with worsened RLS even when haemoglobin is normal. Ask for a ferritin level specifically, as standard iron panels or full blood counts may not reveal borderline deficiency. Certain medications worsen RLS substantially. Antidepressants, particularly SSRIs, SNRIs, and mirtazapine, are among the most common culprits. Antihistamines including diphenhydramine found in over-the-counter sleep aids are also significant triggers. Dopamine-blocking antiemetics such as metoclopramide should be avoided. Alcohol and caffeine, particularly in the evening, worsen symptoms in many women. A heavy evening meal and heat such as a hot bath close to bedtime can also aggravate the evening circadian peak. Pregnancy is a well-known trigger, and many women who had RLS in pregnancy are more susceptible during perimenopause.
Lifestyle and Non-Pharmacological Management
Several non-pharmacological strategies help manage RLS symptoms. Establishing a consistent sleep schedule reduces the circadian burden. Going to bed late enough to reduce the time spent lying awake with symptoms is often more effective than trying to achieve an early bedtime. Light to moderate exercise in the afternoon has evidence for reducing RLS symptom severity, though vigorous late-evening exercise can worsen symptoms in some women. Mental engagement before bed, such as reading, problem-solving, or using a tablet or phone (with blue light filter), may distract from mild symptoms and delay onset. Walking, stretching, and self-massage of the legs during symptomatic periods provides temporary relief. Warm baths of moderate temperature can help initially before bedtime though very hot baths should be avoided. Compression leg wraps or pneumatic compression devices provide surface pressure that some women find suppressive of the urge to move. Iron supplementation to achieve a ferritin level above 75 should be the first treatment tried where deficiency is confirmed.
Medical Treatment Options
For moderate to severe RLS that significantly disrupts sleep and quality of life, pharmacological treatment is effective. Dopamine agonists, specifically pramipexole and ropinirole, are approved specifically for RLS and work by directly stimulating the dopamine pathways that are deficient in the condition. They are taken two to three hours before bedtime. They are effective but carry the risk of a phenomenon called augmentation, where over time symptoms start earlier in the day, spread to other body parts, and become more intense. For this reason, international guidelines now recommend starting with alpha-2-delta calcium channel ligands such as pregabalin or gabapentin as first-line treatment, reserving dopamine agonists for cases where other options fail. Low-dose opioids such as codeine or oxycodone are used for severe refractory cases. Benzodiazepines are not recommended as they impair sleep architecture. Any treatment plan should be discussed with a GP or neurologist familiar with RLS.
HRT and Restless Legs in Perimenopause
The relationship between HRT and RLS is complex and currently not resolved by high-quality clinical trial data. Some women report significant improvement in RLS symptoms after starting HRT, consistent with the hypothesis that restoring estrogen and progesterone normalises dopaminergic tone and reduces the neurological sensitivity that drives symptoms. However, other data suggest that oral estrogen combined with progestins may worsen RLS in some women, potentially because of the progestin component. Progesterone itself in micronised form (body-identical progesterone such as Utrogestan) may have a different effect than synthetic progestins and is generally better tolerated neurologically. Transdermal estrogen avoids the first-pass liver effects of oral preparations. If you are considering or already using HRT and have RLS, keeping a symptom diary to track the relationship between your HRT regimen and symptom patterns is valuable. Sharing this with a menopause specialist who also has understanding of RLS allows an informed, personalised approach to both conditions.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.